Monday, November 4, 2019
Investorideas.com - Cannabis Stock News: Supreme Cannabis (TSX: $FIRE.TO) (OTCQX: $SPRWF) Strengthens Sales Strategy with New Senior Vice President of Commercial
Investorideas.com - Cannabis Stock News: Supreme Cannabis (TSX: $FIRE.TO) (OTCQX: $SPRWF) Strengthens Sales Strategy with New Senior Vice President of Commercial
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $META.V), (NYSE: $APHA), (CSE: $COOL.C), (TSXV: $WL.V), (OTC: $EDXC), (CSE: $VIDA.C)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $META.V), (NYSE: $APHA), (CSE: $COOL.C), (TSXV: $WL.V), (OTC: $EDXC), (CSE: $VIDA.C)
Delta, Kelowna, BC –November 4, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/11041META-APHA-COOL-WL-EDXC-VIDA.asp
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts
In today’s podcast we look at a few early announcements.
National Access Cannabis Corp. (TSXV: META), Canada's largest publicly traded recreational cannabis retailer by revenue, announced that it has registered "Meta Growth" as a business name and will begin to conduct business under the Meta Growth name effective immediately, with the formal name change to Meta Growth Corp. subject to shareholder approval. The Company also announced that it has entered into a definitive agreement (the "Agreement") to sell the Company's portfolio of medical cannabis clinics from National Access Canada Corporation to Evergreen Pacific Insurance Corporation for $4 million in cash, anticipated to close on November 30, 2019.
The Meta Growth corporate identity embodies the Company's strategy to be the preeminent cannabis retailer in Canada. The new corporate logo visually represents META's multidimensional commitment to cannabis culture, strength, passion and unique presence in the industry as pure play retail. All new recreational cannabis retail stores will be constructed under the new, cool and comfortable META banner. The Company has unveiled an updated investor presentation as part of this new identity, which is available on its new website, metagrowth.com.
"Aligning our corporate brand, with our retail brand and our stock ticker demonstrates our commitment to the Canadian retail market and creating value for our shareholders", said Mark Goliger, CEO of Meta Growth. "As the cannabis industry has evolved, our focus has shifted from medicinal to recreational cannabis, and today, retail is our portfolio and our future. Brand recognition and consistency are key to our success and META is ready to continue to maintain our leadership position in the Canadian retail market.”
Meta Growth and Evergreen Pacific announced that a definitive agreement to sell the Company's non-core medical cannabis clinics has been executed. Meta Growth intends to use the net proceeds of the sale to fund the buildout of recreational cannabis retail stores, and for general working capital purposes. The transaction is subject to customary closing conditions and is expected to close on or about November 30, 2019.
"As Canada's largest recreational cannabis retailer, with a well-defined growth path ahead of us, this Agreement represents META's focus to maintaining its leadership position in the Canadian retail market, which we view as the most strategic and valuable portion of the recreational cannabis value chain," said Mark Goliger. "We are proud of META's medical cannabis roots and I would like to thank all of the employees who have had a role in growing this division over the past 3 years. This transaction allows us to monetize a non-core asset and redeploy the proceeds into our primary business unit, with a view to optimizing long-term returns on capital and generating shareholder value."
Aphria Inc. (TSX: APHA) (NYSE: APHA) announced that it has received a cultivation licence from Health Canada for Aphria Diamond, the Company's second Leamington, Ontario cannabis greenhouse facility, bringing an additional 1,300,000 square feet of production space with an annual growing capacity of 140,000kg. Combined with the Company's Aphria One facility and its subsidiary Broken Coast Cannabis, the Company now has more than 2,400,000 square feet of cultivation space capable of reaching a total annualized production capacity of 255,000kg.
"We are extremely pleased to receive the licence for our long-awaited Aphria Diamond facility, which more than doubles our Canadian production capacity," said Irwin D. Simon. "Reaching industry-leading production levels coinciding with the expansion into new categories and new opportunities for cannabis in Canada and around the world is a transformative moment for Aphria Inc."
Aphria Diamond is a 51%-owned subsidiary of Aphria Inc., through which the Company has partnered with Double Diamond, a company with multi-generational expertise in the commercial greenhouse industry. Aphria Diamond is situated on a 100-acre campus with a brand-new greenhouse facility covering 1,300,000 square feet that has been retrofit for the cultivation of cannabis.
Aphria Diamond features the industrial-scale automation technology that is the hallmark of Aphria One's Part IV and V expansions. The in-house designed automation will handle cultivation functions including transplanting cuttings, transporting plants through harvesting, de-budding and trimming, drying and curing, and waste disposal.
"We believe the introduction of our proprietary automation technology at Aphria Diamond will provide us with the ability to cultivate high-quality cannabis with great efficiency and at an unprecedented scale," continued Simon. "As we remain focused on sales growth and profitability, this unique advantage is expected to enable Aphria to continue to create long-term value and drive the evolution of the industry through innovation and the development of leading brands."
Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) announced that it has signed a Definitive Agreement to acquire Rainy Daze Cannabis Corp., a British Columbia corporation. The corporation's assets include a long term lease for a facility currently under construction and scheduled to be completed in the 2nd Qtr of 2020. The facility comprises 2,210 square feet of canopy space and 3,500 square feet of operational purpose built building. Also included are 15 top proprietary genetics with the necessary farming protocols and SOPs to ensure both maximum yield and compliance.
The corporation being acquired was organized by Chadwick Clelland, currently CEO of a fully licensed Canadian LP with Cultivation and Medical Sales licenses. The facility under construction has a license application in process.
The facility will be operated by experienced staff with LP credentials. Seed to sale software and distribution agreement will guarantee shelf space with a group of over 12 licensed locations in western Canada. This is an opportunity to independently brand all of Core One Labs' products in the Canadian market. Extraction capabilities on site will permit this corporation to enter the edibles and extracts markets.
With this acquisition, Core One Labs will be positioned to build a foundation in Canada for national distribution and international export of all COOL products, including CannaStripsTM.
The CEO of Core One Labs Inc., Brad Eckenweiler, commented, "The estimated revenue numbers for this facility, when completed, suggest an ROI of over fifty percent annually. The guaranteed flower purchase with a growing number of licensed dispensaries is very attractive to the COOL business model for Canada. The location of the facility in British Columbia where COOL currently has offices is an additional benefit." The Company will continue to update the market on the progress of this project as we proceed to its completion.
Westleaf Inc. (TSX-V:WL) (OTCQB:WSLFF) announced that the conditions precedent to the white-label cannabis derivative product sale agreement between the Company's wholly owned subsidiary Westleaf Labs LP and Delta 9 Cannabis Inc. (TSX: DN) (OTCQX: VRNDF) have been completed, and Westleaf Labs has received the first order from Delta 9 for an initial three-month supply of vape pens and cartridges. This first order represents anticipated revenue of ~$740,000 starting as early as January 2020.
"This is another important milestone in the development of Westleaf, as we add the critical processing and manufacturing component to our vertically integrated strategy," said Scott Hurd, President and CEO of Westleaf. "This operationalizes a key component in the cannabis supply chain and one that we expect will see increase in demand as we enter Cannabis 2.0, and the legalization of a myriad of new products."
The White-Label Agreement provides for Westleaf Labs to produce a minimum of ~$4 million of white labelled cannabis derivative products, with the option to increase to $16 million per annum. The one-year agreement was announced on July 24th and Westleaf Labs received its Health Canada Standard Processing Licence on October 11th and is set to begin processing.
The White-Label Agreement is expected to create value added products to be sold through both Delta 9's retail stores in Manitoba, through Westleaf's wholly-owned Prairie Records stores in Saskatchewan as well as through provincial wholesalers.
With the onset of Cannabis 2.0 and the legalization of a wide variety of new derivative cannabis products, Westleaf is expecting strong industry wide demand for efficient and high-quality extraction, processing and product manufacturing to meet the needs of the new product manufacturers.
Also working with Delta 9, NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) provided an update regarding its operations in Canada, along with its Canadian partner, Delta 9 Cannabis Inc.
The company announced that Delta 9 has filed a Notice of New Cannabis Product Application with Health Canada and will be proceeding to produce commercial batches of an ingestible cannabis oil using Nanosphere patented technology. Once produced, the initial commercial batches will require final review and approval by Delta 9 and Health Canada prior to being sold under the Delta 9 – Evolve brand in the Canadian Market.
Per NanoSphere Health Sciences CEO, Dr. Mark Percival: “This marks an important phase in our company’s development and our entry into the Canadian Market. It also marks the beginning for Canadian consumers who are looking to expand on the benefits they have experienced using cannabis products. The new products being launched by Delta 9 are the first in Canada to utilize aspects of our patented NanoSphere Delivery System. Medical cannabis patients and seasoned recreational users alike will appreciate the difference more effective delivery makes to their experiences”.
CBD Unlimited, Inc. (OTC: EDXC) formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, announced a momentous advancement of the company’s new partnership with First Foods Group, Inc. (OTCQB: FIFG), a leading chocolate manufacturer, to launch hemp-based premium chocolate product line under the brand name, “Southeast Edibles.”
Backed by a proven track-record, First Foods Group will assist in furthering CBD Unlimited’s goals of continuously expanding and innovating its product suite. First Foods Group has launched its first hemp-based chocolate product line under the name Southeast Edibles. CBD Unlimited will play a significant role in regulating the distribution, as well as assisting with the development of high-quality CBD-infused chocolates. Critical applications provided under the agreement include identifying unique food concepts, funding options, and manufacturing services.
Through this collaboration, First Foods Group and CBD Unlimited expect this initial launch to promote the continued development of distinctive ingestible CBD products. Southeast Edibles will offer a variety of premium chocolate flavors with different concentrations of CBD Unlimited’s top-rated CBD.
“First Foods Group will be a significant contributor to CBD Unlimited's growth strategy as we advance into the food category. According to Arcview Market Research, U.S. CBD sales are expected to hit $20 billion by 2024. As this forecast includes the increase in CBD-infused food products, we are excited to accelerate into this market," commented Todd Davis, CEO & Chairman of CBD Unlimited. "We look forward to working closely with First Foods Group and leveraging their knowledge and expertise in CBD-infused food innovation.”
“We are excited to work with CBD Unlimited to bring our newly launched Southeast Edibles product line to market. Our thorough, thoughtful approach to developing only the highest quality CBD chocolate edibles is an ideal match with CBD Unlimited's scientific approach to perfecting the accuracy of CBD dosage in all-natural food products. CBD Unlimited’s loyal customer base and expanding market access gives us confidence that they are an ideal partner to help bring our products to discerning customers who demand quality chocolate edibles that have an exceptional taste and deliver a consistent and reliable dose of hemp-based ingredients,” according to Harold Kestenbaum, CEO and Chairman of FIFG.
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) announced the closed beta launch of its e-commerce site, Wikala.com, an online CBD marketplace for US vendors. Phivida previously launched the private beta for its accessories site in May, 2019, following its acquisition of Wikala.com Inc., which was subsequently rebranded as Bloomgroove.com and released live in September 2019.
Wikala is now live in closed beta and, while it is not yet available for general access, it is presently populated with Phivida's current roster of products. In addition, the site is also in closed beta for independent businesses that can register through the sellers' portal. Once the sign-up process is complete, and Wikala has fully launched, approved vendors will be able to create digital storefronts to list and sell CBD products across the United States. Wikala is expected to be fully live for online shopping on December 1, 2019.
Wikala will provide leading CBD product companies in the industry with a new and robust sales channel that can expand their consumer reach. Through Wikala, Phivida is building a standalone CBD marketplace in the United States. Wikala is aimed at providing an online shopping option that will connect customers directly to third party sellers and manufacturers.
David Moon, President of Wikala.com Inc., commented: "We're excited to see this vision finally coming together. We've gotten some great feedback that has allowed us to refine the integration between customer and vendor. We're continuing to make the necessary tweaks, and we will be using this final open beta stage to ensure we get the process right."
Jim Bailey, Chief Executive Officer of Phivida, added: "Wikala will provide us with direct access to both the vendor and customer, allowing us to focus on providing the best possible shopping experience. By connecting customers with high-quality CBD vendors, we expect this aspect of our business to be less exposed to the stringent regulatory requirements that are required in the traditional bricks and mortar retail channel."
What sets Wikala apart from other eCommerce sites is its proprietary technology. Wikala is a highly customizable online platform that offers merchants powerful features that, to Phivida's knowledge, no other CBD online stores currently offer. Platform features now include a streamlined seller dashboard, advanced smart search, and product comparison tools, among others.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
#CBD Sector Continues to Mature – Sector Snapshot on CBD Brands and Opportunities (OTC: $RLBD) and (NYSE: $ACB), (NYSE: $APHA), (OTC: $TGIFF)
#CBD
Sector Continues to Mature – Sector Snapshot on CBD Brands and Opportunities
(OTC: $RLBD) and (NYSE: $ACB), (NYSE: $APHA), (OTC: $TGIFF)
Point
Roberts WA, Delta BC – November 4, 2019 - Investorideas.com, a leading
investor news resource covering cannabis and hemp stocks releases a sector
snapshot reporting on the growth of the CBD industry and how companies are
looking to differentiate their unique brands.
According
to a report ‘Trends in Internet
Searches for Cannabidiol (CBD) in the United States’, Google searches
for CBD are seeing exponential growth as popularity and availability increases.
”Searches for CBD are now rivaling searches for yoga and electronic cigarettes,
with 0.96 and 0.85 of their respective search volumes, and are searched for
more than half as much as dieting.”
Another
recent
report
stated, “As applications for cannabidiol are brought to market across diverse
industries such as cosmetics, health products, food and beverage, pet products,
skin care, and pharmaceuticals, the collective market for CBD sales is expected
to exceed $20 billion in the United States by 2024,” according to BDS
Analytics
and Arcview Market Research.
“We’re
witnessing CBD maturing from a cannabis sub-category into a full-blown industry
of its own,” said Roy Bingham, Co-Founder and CEO of BDS Analytics. “Our growth
forecast for the CBD market, across all distribution channels, predicts a
compound annual growth rate of 49 percent by 2024. This is a great opportunity
for all involved, but it means the road ahead will include decisions that need
to be informed by the best possible data.”
As
major retailers continue to announce their stocking and private label
development of CBD products, BDS Analytics predicts that the majority of CBD
product sales will soon occur in general retail stores, rather than cannabis
dispensaries, as is currently the case. Moving forward, BDS Analytics market
insights indicate that the success of products is dependent on education and
understanding, dosing and consistent labeling.
BDS
Analytics feels CBD is in a unique position compared to other nutraceutical or
supplement ingredients for two reasons: 1) as an active ingredient in cannabis,
it has a storied history of health and wellness use and anecdotal evidence of
efficacy, and 2) it is one of the few natural remedies with scientific basis
for at least some of the claims being made about its curative powers.
Unsurprisingly, consumers are fascinated by the perceived benefits of CBD.
This
growth and drive of the CBD industry is bringing in major branding
opportunities such as sports and celebrity endorsements for each innovative
formula.
Real Brands, Inc. (OTC:
RLBD),
a leading brand building company in the legal Hemp-Derived CBD consumer
products category, announced that it has closed
the previously announced acquisition of the proprietary CBD formulas from
Integrative Medicine US of Coral Springs, Florida. The formulas consist of
Ancient Chinese and other Ancient Herbal Remedies that are paired with the
latest scientific breakthroughs in endocannabinoid systems, nutrients and
hemp-derived CBD.
“We
are pleased to announce the signing of the definitive agreement to acquire
these proprietary formulas," said Real Brands, Inc. CEO, Jerry Pearring.
“Since completing our audit earlier this month, we are now focusing on
launching our brands and E-commerce website,” added Pearring. “We are
concluding the final steps in developing our unique packaging design and
formulations for each of our brands: CBD Pharmacy™, HempAid®, Humboldt Brands®
and Omegahemp™. This acquisition bolsters our efforts to offer consumers
innovative CBD products and, as we previously announced, we intend to use these
formulas for our CBD Pharmacy™ brand and feature the Chinese symbol for healing
in our new logo.”
In
addition, as part of this acquisition, Jonathan Fields, AP DOM, has entered
into an agreement to formulate additional products for Real Brands and become
the initial member of Real Brands, Inc.’s Advisory Board. “I’m pleased to
become a member of the Real Brands team and look forward to applying my
education and ongoing research into traditional eastern medical therapies to
create delivery mechanisms that act synergistically with CBD,” said Fields.
Aphria Inc. (TSX:
APHA)
(NYSE:
APHA)
recently
reported
its results for the first quarter ended August 31, 2019, with a net revenue of
$126.1 million in the first quarter, an increase of 849% from prior year
quarter and a decrease of 2% from the prior quarter, revenue for adult-use
cannabis of $20.0 million in the first quarter, an increase of 8% from the
prior quarter and a net income of $16.4 million and adjusted EBITDA of $1.0
million in the first quarter.
"We
are pleased to report a second consecutive quarter of profitable growth with
strong contribution from our Canadian cannabis operations. Our success was also
driven by our international business and the strength and growth of our brands,
particularly Broken Coast, despite a small fire at our British Columbia
facility at the end of the quarter. This solid start to the year keeps us on
track to achieve our fiscal year 2020 financial outlook," stated Irwin D.
Simon, CEO of Aphria, Inc. "Going forward, we remain focused on our
highest-return priorities both in Canada and internationally as our team
furthers the development of our medical and adult-use cannabis brands to drive
growth through innovation and return value to shareholders."
The
company, through its subsidiary Aphria
Deutschland GmbH launched their CBD-based
nutraceutical, featuring CBD derived from hemp, CannRelief. The brand of
products are being produced in the European Union and distributed by the Company's
subsidiary, CC
Pharma,
which has access to more than 13,000 pharmacies throughout Germany.
"We
are excited to introduce our first brand of CBD products for the German
nutraceutical and cosmetics market," said Jakob Ripshtein, President of
Aphria. "Supported by our extensive distribution network through CC
Pharma, CannRelief provides a natural extension to Aphria's growing business
opportunities in the German medical cannabis market. We look forward to
providing a full range of CannRelief CBD products this year."
CannRelief
CBD oils are being sold in both a 5% and 10% CBD concentration and can be found
in select stores across Germany. A range of skincare and other products,
including creams, serums and masks will be introduced under the CannRelief
brand in a phased rollout in 2019.
Aurora Cannabis
Inc.
(NYSE:
ACB)
(TSX:
ACB),
a Canadian company that's defining the future of cannabis worldwide, and the UFC, the world's premier mixed martial
arts organization, announced their launch of a
joint clinical research program that will produce multiple studies under the
terms of their recently announced partnership.
The ground-breaking research partnership is
aimed at understanding key health and recovery needs of elite athletes in such
a highly physical and competitive sport as mixed martial arts. Research data
will then be used to drive the development of science-backed, hemp-derived CBD
topicals that will be safe and reliable. These new products will help combat
the rapidly growing market of untested CBD treatments currently being used by
high-performance and non-professional athletes.
Once research is complete, any resulting
product will come to life in the US under the new high-performance sports brand
ROAR Sports, a portfolio of high-quality, hemp-derived CBD topical treatments
scientifically formulated with elite athletes in mind. Through analysis of
athlete needs and scientific data, ROAR Sports will challenge the status quo,
seek to alleviate the stresses of competition, and earn designation as the
"Official CBD product of UFC."
The multi-phase clinical study at the UFC
Performance Institute® in Las Vegas will be led by Dr. Jason Dyck,
Chair of Aurora's Global Scientific Oversight Committee; Dr. Kelly Narine,
Aurora's Vice President Global Research and Medical Affairs; and the team of
sports performance experts at the UFC Performance Institute, led by Dr. Duncan
French, UFC Vice President of Performance. Using active UFC athletes on a
strictly voluntary basis, the study will help establish peer-reviewed,
publishable research in this area. Products will be developed in full
compliance with U.S. federal law and with UFC's anti-doping program, which
adheres to WADA and USADA regulations.
"Our partnership with UFC is about
committing to the science that will educate and advocate," said Aurora
CEO, Terry Booth. "We are going to work together to change the way people
think, to change the industry, and to launch the first hemp-derived CBD
products that are backed by scientific research. The brand-building and product
development are all part of our move into the U.S., and in collaboration with
UFC, and we intend to play a major role in that market."
"We know anecdotally that professional
athletes across sports disciplines are turning to hemp-derived CBD treatments
to assist with physical recovery, with varying degrees of success," added
Jason Dyck, Chair of Aurora's Global Scientific Oversight Committee. "The
work we do in partnership with UFC will create an evidence-based,
science-backed pipeline of consistent, and 'clean' hemp-derived CBD topicals
that the high-performance athletes of UFC can rely on to treat the pain,
inflammation, injury and other conditions associated with competing at such a
high level."
"Collaborating with Aurora is the best
way to educate ourselves and our fighters about the impact of CBD on MMA
athletes and our sport," said Dr. Duncan French, UFC's Vice President of
Performance. "We want to apply science and see where it leads us. Ideally, these studies will give us the
clarity we need to determine the effectiveness of hemp-derived CBD on athlete
health and injury recovery."
"Although CBD is allowed under USADA
and WADA regulations, we want to be the leaders on educating UFC athletes on
CBD use," said Jeff Novitzky, UFC Senior Vice President of Athlete Health
& Performance. "Athlete safety is a top priority for UFC, and we will
collaborate with Aurora to ensure that any new products are third-party tested
for all WADA-prohibited substances to make certain they meet WADA
standards."
1933 Industries
Inc. (CSE:
TGIF)
(OTC:
TGIFF),
a vertically integrated cannabis consumer packaged goods company, recently
announced
that it will introduce its newest product, the Birdhouse CBD Balm by Canna Hemp
X™, on November 4th, 2019. The CBD Balm was developed in
collaboration with Birdhouse Skateboards™, targeting the action sports market
and will be available for sale in dispensaries, wellness stores, skate shops
and specialty retailers, including Zumiez in the United States.
Focusing
on the wellness market through the creation of innovative products that enhance
and improve people's lives, the Company's CBD-infused line is nationally
recognized for its quality and purity of ingredients. Building on its already
successful Canna Hemp X™ brand, the new Birdhouse CBD Balm is a must-have for
any athlete in need of fast results before, during, and after exercise. The
quick-acting Birdhouse CBD Balm is specially formulated with a blend of
essential oils, arnica, peppermint, menthol and other natural ingredients. With
broad-spectrum CBD, all Canna Hemp™ products are nanoparticulated to ensure
total transdermal absorption for maximum effects, while being 100% THC-free.
The
sports world is fast embracing the use of cannabidiol or CBD, one of over 100
non-psychoactive and non-addictive compounds extracted from the cannabis plant,
in a variety of new products aimed at enhancing performance and recovery. Pro
and amateur athletes are now advocating CBD as an alternative to opioid use.
"We are just starting to scratch the surface of the many applications
associated with the cannabis plant and we are pleased to be part of a national
conversation about its potential. The anecdotal benefits keep mounting and we
believe that this market is underserved," commented Mr. Chris Rebentisch,
1933 Industries CEO.
He
added, "We constantly improve our formulations through research and we
worked closely with the Birdhouse team over several months to develop a
next-generation CBD topical product that would have wide appeal in the sports
world. We are pleased to unveil the Birdhouse CBD Balm that both companies are
proud to endorse."
Internationally
recognized skateboarding legend Mr. Tony Hawk, Founder of Birdhouse
Skateboards™ said, "The Birdhouse CBD Balm is our first collaboration with
the team at Canna Hemp X™ and was created with skateboarders and athletes of
all levels in mind. Sports like skateboarding require the highest quality
recovery products to sustain longevity. We also hope to create awareness of the
potential of CBD and in making natural products more accessible
nationwide."
As
this CBD industry continues to grow, in many ways almost independent of the
cannabis sector, brand awareness will become essential as consumers gain more
familiarity and awareness of the Hemp/CBD space. As one recent news piece put
it, “CBD
now has ‘a life of its own’”, and it will be the companies able to build their
brands out early through sponsorship agreements, as well as show consistent
quality of their innovative formulas that will stand ahead of the rest.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third
party news, research and original financial content. Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news
column, Investor
Ideas Potcasts Cannabis News and Stocks on
the Move podcast and column, Cleantech and Climate Change , Exploring Mining, the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses of all investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure:
this news article featuring Real Brands, Inc. RLBD is a paid for news release
on Investorideas.com – third party (two thousand) More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on
the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Get more Cannabis Stock
Investor Ideas - news, articles, podcasts and
stock directories
Friday, November 1, 2019
Investorideas.com - Cannabis Stock News: SOL Global (CSE: SOL) (OTCPK: SOLCF) Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares
Investorideas.com - Cannabis Stock News: SOL Global (CSE: SOL) (OTCPK: SOLCF) Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Subscribe to:
Posts (Atom)